Baseline patient characteristics were well-balanced, including kidney function and albuminuria status. The primary endpoint ...

The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating ...

Roughly 2.85 million patients with a qualifying hospital visit were identified with either clinical CKD or at risk for CKD.

In addition to a 24% reduction in major kidney disease events, the semaglutide group had 18% less MACE at 3 years versus ...

In this cohort study of living kidney donors and nondonors with the same follow-up schedule, the risks of hypertension and albuminuria were not significantly different. After the initial drop in ...

In California, Gov. Gavin Newsom (D) signed a law allowing some Arizona doctors to become temporarily licensed there and ...

Epidemiologic evidence indicates that the presence of albuminuria is predictive of increased cardiovascular morbidity and mortality independent of other cardiovascular risk factors. [4] There is a ...

From the Division of Cardiology, Department of Medicine (D.H.K., S.S., F.G.A., E.E.M., L.B., S.J.S.) and Department of Preventive Medicine (K.-Y.A.K., J.P ...

From the Division of Cardiology, Department of Medicine (D.H.K., S.S., F.G.A., E.E.M., L.B., S.J.S.) and Department of Preventive Medicine (K.-Y.A.K., J.P ...

In the section entitled “Functional Surrogate Markers” we will explore blood pressure, endothelial dysfunction, arterial wall compliance or stiffness, and albuminuria. These have all been demonstrated ...

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction ...